Profound Medical (PROF)
(Delayed Data from NSDQ)
$7.80 USD
-0.02 (-0.19%)
Updated Apr 17, 2024 03:59 PM ET
After-Market: $7.76 -0.04 (-0.45%) 7:08 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
PROF 7.80 -0.02(-0.19%)
Will PROF be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for PROF based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PROF
Profound Medical (PROF), Siemens Unite to Treat Prostate Cancer
Enanta Pharmaceuticals (ENTA) Reports Q1 Loss, Lags Revenue Estimates
PROF: What are Zacks experts saying now?
Zacks Private Portfolio Services
Profound Medical (PROF) Soars 9.4%: Is Further Upside Left in the Stock?
How Much Upside is Left in Profound Medical (PROF)? Wall Street Analysts Think 66.06%
Strength Seen in Profound Medical (PROF): Can Its 19.5% Jump Turn into More Strength?
Other News for PROF
Profound Medical to Participate in the 2024 Bloom Burton & Co. Healthcare Investor Conference
Profound Medical to Present at Healthcare Investor Conference
Profound Medical to Update at Healthcare Conference
Profound Medical price target lowered by $1.95 at Alliance Global Partners, here's why
Profound Medical Announces Fourth Quarter and Full Year 2023 Financial Results